Randomized double-blind trial of darbepoetin alfa in patients with symptomatic heart failure and anemia

Circulation
Jalal K GhaliStudy of Anemia in Heart Failure Trial (STAMINA-HeFT) Group

Abstract

Substantial evidence suggests that anemia is an independent risk factor for worse outcomes in patients with heart failure (HF). The Study of Anemia in Heart Failure Trial (STAMINA-HeFT) is the largest multicenter, randomized, double-blind, placebo-controlled trial to date evaluating the effect of treating anemia in HF. Patients (N=319) with symptomatic HF, left ventricular ejection fraction < or = 40%, and hemoglobin > or = 9.0 g/dL and < or = 12.5 g/dL were randomized (double-blind) to placebo (N=157) or darbepoetin alfa (N=162) subcutaneously every 2 weeks for 1 year (target hemoglobin, 14.0+/-1.0 g/dL). The primary end point was change from baseline to week 27 in treadmill exercise time. Secondary end points were change from baseline in New York Heart Association class and quality of life at week 27. An additional prespecified efficacy analysis included the time to death by any cause or first HF-related hospitalization by 1 year. At baseline, the median (interquartile range) hemoglobin was 11.4 (10.9, 12.0) g/dL. At week 27, darbepoetin alfa treatment increased median (interquartile range) hemoglobin by 1.8 (1.1, 2.5) g/dL (placebo, 0.3 [-0.2, 1.0] g/dL; P<0.001). Of the patients treated with darbepoetin alfa, 85% achieved 2...Continue Reading

Associated Clinical Trials

References

Oct 5, 2001·Journal of the American College of Cardiology·A Al-AhmadM J Sarnak
Oct 23, 2002·Circulation·Milton PackerUNKNOWN Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study Group
Mar 4, 2003·Nature Biotechnology·Steve ElliottJoan Egrie
Apr 2, 2003·The American Journal of Cardiology·Paul R KalraStefan D Anker
Jun 12, 2003·Journal of the American College of Cardiology·Dariush MozaffarianWayne C Levy
Aug 29, 2003·The American Journal of Cardiology·G Michael FelkerChristopher M O'Connor
May 8, 2004·American Heart Journal·Klaus K A WitteAndrew L Clark
Jun 24, 2004·Circulation·Inder AnandPaul B J Burton
May 4, 2005·The American Journal of Medicine·Giuseppe ZuccalàRoberto Bernabei
Nov 17, 2006·The New England Journal of Medicine·Tilman B DrüekeUNKNOWN CREATE Investigators
Nov 17, 2006·The New England Journal of Medicine·Ajay K SinghUNKNOWN CHOIR Investigators

❮ Previous
Next ❯

Citations

Apr 8, 2011·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Armin ZittermannJochen Börgermann
Oct 29, 2009·Cardiovascular Drugs and Therapy·Faramarz TehraniBojan Cercek
Apr 9, 2008·Heart Failure Reviews·Clare L Murphy, John J V McMurray
Sep 4, 2008·Current Heart Failure Reports·Haroon A FarazJalal K Ghali
Sep 4, 2012·Current Heart Failure Reports·Shanti Gunawardena, Mark E Dunlap
Nov 26, 2008·Current Treatment Options in Cardiovascular Medicine·George MakKenneth McDonald
Oct 4, 2011·Current Treatment Options in Cardiovascular Medicine·Kelly H Schlendorf, Edward K Kasper
Apr 9, 2009·Nature Reviews. Cardiology·Gerald W Dorn
Jun 2, 2011·Nature Reviews. Cardiology·Dirk J van VeldhuisenIain C Macdougall
Sep 30, 2009·Nature Reviews. Nephrology·M Khaled Shamseddin, Patrick S Parfrey
Apr 29, 2010·Nature Reviews. Nephrology·Walter H Hörl
Dec 19, 2012·Nature Reviews. Nephrology·Parta HatamizadehKamyar Kalantar-Zadeh
Mar 12, 2013·The New England Journal of Medicine·Karl SwedbergUNKNOWN RED-HF Investigators
Oct 27, 2012·European Heart Journal·Ewa A JankowskaPiotr Ponikowski
May 14, 2011·International Journal of Clinical Practice·M R Cowie, R Lucas
Oct 28, 2008·American Journal of Physiology. Heart and Circulatory Physiology·Sharad RastogiHani N Sabbah
Sep 14, 2011·Cardiology·Michael N ZairisStefanos G Foussas
May 29, 2009·Circulation Journal : Official Journal of the Japanese Circulation Society·Shinya HiramitsuYukio Ozaki
Feb 14, 2013·Clinical Interventions in Aging·Ravish Shah, Anil K Agarwal
May 24, 2011·Vascular Health and Risk Management·Pablo Pazos-LópezAlfonso Castro-Beiras
Apr 22, 2010·Vascular Health and Risk Management·Ankur SandhuAnatole Besarab
May 31, 2011·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Ryan P MorrisseyPrediman K Shah
Apr 24, 2010·Journal of Cardiovascular Medicine·Elena AbateGiovanni M Boffa
Jul 3, 2013·Journal of Cardiovascular Medicine·Vittoria MastromarinoMassimo Volpe
Dec 23, 2010·Future Cardiology·Stephan von HaehlingStefan D Anker
May 15, 2013·Future Cardiology·Carmen CairaFrancesco Fedele
Apr 18, 2009·Future Cardiology·John V TerrovitisJohn N Nanas
Dec 19, 2013·Current Treatment Options in Cardiovascular Medicine·Hanna K Gaggin, G William Dec
Jun 21, 2013·Cardiovascular Drugs and Therapy·Marieke L FokkemaAdriaan A Voors
Aug 12, 2014·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Richard KirkRobert Weintraub
Oct 8, 2011·Heart Failure Reviews·Stephan von HaehlingStefan D Anker
Nov 11, 2010·Current Treatment Options in Cardiovascular Medicine·Eileen O'Meara, Simon de Denus
Oct 25, 2011·Rinshō shinkeigaku = Clinical neurology·Tsuyoshi MatsumuraSaburo Sakoda
Jun 18, 2009·Current Opinion in Cardiology·Jalal K Ghali
Dec 10, 2009·Current Opinion in Cardiology·Thomas D Stamos, Marc A Silver
Nov 5, 2011·Heart Failure Reviews·Lindsey Tilling, Brian Clapp
Feb 23, 2010·Clinical and Experimental Nephrology·Carlo LonghiniFabio Fabbian
Nov 26, 2010·Clinical and Experimental Nephrology·Kosaku Nitta
Oct 12, 2011·Current Opinion in Supportive and Palliative Care·Ewan Tevendale, John Baxter

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Cardiology Journals

Discover the latest cardiology research in this collection of the top cardiology journals.